What's in AMAG Pharmaceuticals, Inc.'s pipeline?

AMAG Pharmaceuticals, Inc. has 3 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with AMAG Pharmaceuticals, Inc.'s portfolio?

Top competitors by shared drug class: Albina Nowak, MD, American Regent, Inc., Mallinckrodt, Medical University of Vienna, NICHD Global Network for Women's and Children's Health.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/amag-pharmaceuticals-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

AMAG Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief

AMAG Pharmaceuticals, Inc. pipeline: 0 marketed, 0 filed, 2 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
ferumoxytol or oral iron	ferumoxytol or oral iron	phase 3	Iron replacement therapy		Hematology
FCM	FCM	phase 3	Intravenous iron replacement agent	Iron (Fe3+) delivery via transferrin-mediated uptake	Hematology

Therapeutic area mix

Hematology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Albina Nowak, MD · 1 shared drug class
American Regent, Inc. · 1 shared drug class
Mallinckrodt · 1 shared drug class
Medical University of Vienna · 1 shared drug class
NICHD Global Network for Women's and Children's Health · 1 shared drug class
Nicoletta C Machin · 1 shared drug class
Oregon Health and Science University · 1 shared drug class
Pharmacosmos A/S · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for AMAG Pharmaceuticals, Inc.:

Cite this brief

Drug Landscape (2026). AMAG Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/amag-pharmaceuticals-inc. Accessed 2026-05-16.